Building Trust in Sickle Cell Disease
Clinical Development Through
Authentic Patient Partnership

Key learnings and recommendations
for embedding patient voices across
the clinical development journey.

The RISE UP clinical trial program, campaign and white paper were sponsored by Agios Pharmaceuticals, Inc. Advisory board members were compensated for their participation in advisory activities related to the clinical trial and campaign during its development. Medical writing support was provided by FleishmanHillard and funded by Agios Pharmaceuticals, Inc.

Click to download

Building Trust in Sickle Cell Disease Clinical Development Through Authentic Patient Partnership

Building Trust in Sickle Cell Disease
Clinical Development Through
Authentic Patient Partnership